Very low doses of Rituximab for autoimmune diseases, for which rituximab is not approved for - a Pilot Trial Autoimmune haemolytic anaemia, antiphospholipid syndrome: To investigate whether 5mg/m2, 20mg or 50mg rituximab suffice to suppress CD20+ cells over a defined period of time Immun...

• Country None
• organs None
• Specialty None

A prospective, randomized, double-blind trial on safety and efficacy of Alprostadil infusion as an additional Anticoagulant (to standard therapy heparin) in patients in need of extracorporeal lung assist therapy (veno-venous extracorporal membrane oxygenation) To measure efficacy of Alprostadil as an additional anticoagulant in patients treated with veno-venous ECMO therapy. Main objective is the reduction in bleeding rate assessed by need of packed red bl...

• Country None
• organs None
• Specialty None